{'fraction_non_alphanumeric': 0.0344275420336269, 'fraction_numerical': 0.017614091273018415, 'mean_word_length': 5.510416666666667, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Polysubstituted Pyrimidines as mPGES-1 Inhibitors: Discovery of Potent Inhibitors of PGE2 Production with a Strong Anti-inflammatory Effects in Carrageenan-Induced Rat Paw Edema.

We report an extensive structure-activity relationship optimization of polysubstituted pyrimidines that led to a discovery of 5-butyl-4-(4-benzyloxyphenyl)-6-phenylpyrimidin-2-amine, and its difluorinated analogue. These compounds are submicromolar inhibitors of PGE 2 production (IC 50 as low as 12 nM). In order to identify the molecular target of anti-inflammatory pyrimidines, we performed extensive studies including enzymatic assays, homology modeling and docking. The difluorinated analogue simultaneously inhibits two key enzymes of the arachidonic acid cascade, namely mPGES-1 and COX-2, where the mPGES-1 inhibition represents the principal mechanism of action. Other pyrimidines studied are potent mPGES-1 inhibitors with no observed inhibition of COX-1/2 enzymes. Moreover, two most potent compounds proved to be significantly effective in vivo in a model of acute inflammation, suppressing the carrageenan-induced rat paw edema by 36% and 46%. Promising results of this study warrant further preclinical evaluation of selected anti-inflammatory candidates.